Ernexa Therapeutics Inc. (ERNA)
NASDAQ·Healthcare·Biotechnology
$0.19
-3.55%
Mkt Cap $2.34M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 13, 2026 | — | — | — | — | -$0.01 | — | — | — |
| Q4 2025 Nov 7, 2025 | — | — | — | — | -$0.15 | — | — | — |
| Q3 2025 Aug 13, 2025 | — | — | — | — | -$0.61 | — | — | — |
| Q2 2025 May 7, 2025 | — | — | — | — | -$2.25 | — | — | — |
| Q1 2025 Mar 12, 2025 | — | $1.00K | — | — | -$1.14 | — | — | — |
| Q4 2024 Nov 12, 2024 | — | $487.00K | — | — | -$4.92 | — | — | — |
| Q3 2024 Aug 13, 2024 | — | $47.00K | — | — | -$1.02 | — | — | — |
| Q2 2024 May 14, 2024 | — | $47.00K | — | — | -$1.23 | — | — | — |
| Q1 2024 Mar 14, 2024 | — | $17.00K | — | — | -$1.14 | — | — | — |
| Q4 2023 Nov 13, 2023 | — | $51.00K | — | — | -$1.03 | — | — | — |
| Q3 2023 Aug 11, 2023 | — | — | — | — | -$0.85 | — | — | — |
| Q1 2023 Mar 20, 2023 | — | — | — | — | -$1.24 | — | — | — |
| Q4 2022 Nov 14, 2022 | — | — | — | -$2.20 | -$2.49 | -13.18% | — | — |
| Q3 2022 Aug 11, 2022 | — | — | — | -$2.60 | -$1.20 | +53.85% | — | — |
| Q3 2022 Jul 1, 2022 | — | — | — | -$2.80 | -$3.40 | -21.43% | — | — |
| Q4 2021 Dec 31, 2021 | — | — | — | — | -$3.25 | — | — | — |
| Q4 2021 Nov 9, 2021 | — | — | — | -$1.60 | -$2.20 | -37.50% | — | — |
| Q3 2021 Aug 13, 2021 | — | — | — | — | -$4.75 | — | — | — |
| Q2 2021 May 17, 2021 | — | — | — | — | -$12.74 | — | — | — |
| Q1 2021 Mar 11, 2021 | — | — | — | — | -$1.60 | — | — | — |